Cargando…
LncRNA HCP5 as a potential therapeutic target and prognostic biomarker for various cancers: a meta‑analysis and bioinformatics analysis
BACKGROUND: Accumulating studies indicated that dysregulated long non-coding RNA human histocompatibility leukocyte antigen (HLA) Complex P5 (HCP5) may functions as an potential prognostic predictor in multiple cancers. This meta-analysis was performed to systematically collect studies and conduct a...
Autores principales: | Hu, Shao-pu, Ge, Meng-xue, Gao, Lei, Jiang, Min, Hu, Kai-wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684676/ https://www.ncbi.nlm.nih.gov/pubmed/34923990 http://dx.doi.org/10.1186/s12935-021-02404-x |
Ejemplares similares
-
LncRNA DUXAP8 as a prognostic biomarker for various cancers: A meta-analysis and bioinformatics analysis
por: Wang, Yongfeng, et al.
Publicado: (2022) -
LncRNA HCP5 : A Potential Biomarker for Diagnosing Gastric Cancer
por: Qin, Shiyi, et al.
Publicado: (2021) -
LncRNA HCP5 promotes follicular thyroid carcinoma progression via miRNAs sponge
por: Liang, Leilei, et al.
Publicado: (2018) -
The Prognostic Value of lncRNA MCM3AP-AS1 on Clinical Outcomes in Various Cancers: A Meta- and Bioinformatics Analysis
por: Fu, Liangyin, et al.
Publicado: (2022) -
Comprehensive analysis of a novel four-lncRNA signature as a prognostic biomarker for human gastric cancer
por: Miao, Yan, et al.
Publicado: (2017)